Mostrando 10 resultados de: 52
Publisher
Bionatura(11)
Biotecnologia Aplicada(7)
Therapeutic Innovation and Regulatory Science(3)
Electronic Journal of Biotechnology(2)
International Journal of Molecular Sciences(2)
A monoclonal antibody against NeuGc-containing gangliosides contains a regulatory idiotope involved in the interaction with B and T cells
ArticleAbstract: P3 (IgM-κ) is a monoclonal antibody (mAb) reacting with N-glycolyl neuraminic acid (NeuGc)-containinPalabras claves:H-CDR3, Idiotype, Monoclonal antibody, N-Glycolyl neuraminic acidAutores:Mier E., Perez A., Rodríguez R., Santiago Nelson Vispo, Vázquez A.M.Fuentes:scopusA theoretical and experimental study on the potential luminescent and biological activities of diaminodicyanoquinodimethane derivatives
ArticleAbstract: Recently, several studies have demonstrated that diaminodicyanoquinone derivatives (DADQs) could prePalabras claves:Fluorescence, Luminescence, quantum yield, Quinones, TD-DFTAutores:Edison Rafael Jiménez, Fernando Javier Torres, Hortensia Rodriguez Cabrera, Manuel Caetano, Santiago Nelson Vispo, Terencio T.Fuentes:scopusCosmix-Plexing: A novel way to generate and use combinatorial phage-display libraries
ArticleAbstract: This work describes the Cosmix-Plexing® procedure. It provides a novel way to use and generate combiPalabras claves:Bacteriophages, Combinatorial libraries, Cosmix-Plexing, Phage-display, RecombinationAutores:Collins J., Horn N., Santiago Nelson Vispo, Szardenings M.Fuentes:scopusAdvances in Clinical Research in Ecuador
ArticleAbstract: Ecuador is undergoing a process of clinical research development and strengthening. At the turn of tPalabras claves:clinical research, clinical trials, Economic development, ECUADOR, PharmaceuticalAutores:Castro K.A., Luis Santiago Escalante, Santiago Nelson Vispo, Thelvia I. Ramos GómezFuentes:scopusCRISPR-Cas9: A Precise Approach to Genome Engineering
ArticleAbstract: In the last few decades, genomic manipulation has made significant progress as a result of the develPalabras claves:bacterial adaptive defense system, clinical trials, CRISPR-Cas9, genetic engineering, NGSAutores:Jorge E. Simón, Rodríguez Á.S., Santiago Nelson VispoFuentes:scopusCancer therapies
OtherAbstract:Palabras claves:Autores:Santiago Nelson VispoFuentes:scopusCellulose-based hydrogels towards an antibacterial wound dressing
ArticleAbstract: Hydrogels are promising candidates for wound healing bandages because they can mimic the native skinPalabras claves:Autores:Camilo Zamora-Ledezma, Dario Niebieskikwiat, Esteban Guamba, Frank Alexis, Santiago Nelson Vispo, Santos-Oliveira R., Singh A.K., Whitehead D.C.Fuentes:scopusAntitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2)
ArticleAbstract: Protein Kinase (casein kinase 2, CK2) is a serine-threonine kinase that is frequently dysregulated iPalabras claves:Autores:Acevedo B.E., Alonso D.F., Falcón-Cama V., López-Mola E., Mendoza O., Perea-Rodríguez S.E., Puchades Y., Reyes O., Santiago Nelson Vispo, Santos-Savio A., Silva R., Torrens I.Fuentes:scopusApplication of the Phage Display Technology for the Development of Peptide- mediated Drug Delivery Systems through the Blood-Brain Barrier
ReviewAbstract: The main obstacle to biopharmaceutical delivery in therapeutic concentration into the brain for treaPalabras claves:blood-brain barrier, drug delivery, molecular trojan horse, Phage display technology, receptor-mediated transcytosis, shuttle peptidesAutores:Ramos O.S., Santiago Nelson Vispo, Suárez V.M.Fuentes:scopusCharacterization of epitopes on human interleukin-2 using phage displayed-peptide libraries: Insights into antibody-peptide interactions
ArticleAbstract: We have characterized the binding epitopes of two monoclonal antibodies (MAbs) reacting with human IPalabras claves:Autores:Araña M.J., Cesareni G., Chinea G., Ojalvo A.G., Santiago Nelson VispoFuentes:scopus